Up until this point, our screening process had identified numerous genes whose siRNAs reduced G6PC mRNA levels in a hormone-responsive hepatoma cell line, thereby suggesting that they might suppress HGP. This evidence concerns the gene G6PC1 and hepatocellular carcinoma.